Aldeyra Therapeutics, Inc.
Combination treatment of ocular inflammatory disorders and diseases

Abstract:

The present disclosure provides a combination of a fused bicyclic amine compound and an anti-inflammatory agent for treating ocular inflammatory disorders and diseases. Further provided are pharmaceutical compositions of the compound and the anti-inflammatory agent.